Trial intelligence / Profile preview

Imaging genetics and gene regulation network study of Gan stagnation in depression

ChiCTR-IPR-14005427Phase 4Not yet recruiting

Sponsor
College of Traditional Chinese Medicine, Southern Medical University
Start
Jan 2013
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, open-label trial of sertraline and xiao yao san in major depressive disorder (MDD) (2 arms), sponsored by College of Traditional Chinese Medicine, Southern Medical University. Primary endpoints: RNA and MRI images. Planned start Jan 2013; status: not yet recruiting.

02

Drugs

sertralinexiao yao san
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on ChiCTR-IPR-14005427.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-14005427.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call